Provided by Tiger Trade Technology Pte. Ltd.

Precision Biosciences Inc

4.49
-0.0300-0.66%
Post-market: 4.500.0101+0.22%19:42 EST
Volume:630.56K
Turnover:2.83M
Market Cap:108.08M
PE:-0.54
High:4.64
Open:4.53
Low:4.37
Close:4.52
52wk High:8.82
52wk Low:3.61
Shares:24.07M
Float Shares:22.82M
Volume Ratio:3.56
T/O Rate:2.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.3225
EPS(LYR):1.05
ROE:-205.16%
ROA:-45.34%
PB:6.50
PE(LYR):4.28

Loading ...

Director Geno J. Germano Acquires Common Shares of Precision BioSciences Inc

Reuters
·
Dec 17

Director Melinda Brown Acquires Common Shares of Precision BioSciences Inc

Reuters
·
Dec 17

H.C. Wainwright Keeps Their Buy Rating on Precision BioSciences (DTIL)

TIPRANKS
·
Nov 21

Precision BioSciences Unveils Positive Phase 1 ELIMINATE-B Trial Results for PBGENE-HBV

Reuters
·
Nov 19

Precision BioSciences Announces Presentation of Clinical Data From the Eliminate-B Trial at Hep-Dart 2025

THOMSON REUTERS
·
Nov 19

Precision BioSciences announces $75M offering of common stock, warrants

TIPRANKS
·
Nov 11

BRIEF-Precision BioSciences Announces $75 Million Offering Of Common Stock, Pre-Funded Warrants And Warrants

Reuters
·
Nov 11

Precision BioSciences Announces $75 Million Offering of Common Stock, Pre-Funded Warrants and Warrants

THOMSON REUTERS
·
Nov 11

Precision BioSciences Reports Positive Phase 1 Results for Gene Editing Therapy in Chronic Hepatitis B

Reuters
·
Nov 11

Precision BioSciences trading halted, news pending

TIPRANKS
·
Nov 11

Precision BioSciences Q3 revenue falls sharply

Reuters
·
Nov 03

Precision BioSciences reports third quarter 2025 revenue of less than $0.1 million and research and development expenses of $13.4 million

Reuters
·
Nov 03

Precision BioSciences Q3 EPS $(1.84) Misses $(1.34) Estimate, Sales $13.000K Miss $5.400M Estimate

Benzinga
·
Nov 03

BRIEF-Precision BioSciences, Inc. Q3 Revenue USD 13 Thousand

Reuters
·
Nov 03

Precision BioSciences Inc - Ind Filing for Pbgene-Dmd Expected by End of 2025

THOMSON REUTERS
·
Nov 03

Precision BioSciences Inc - Expected Cash Runway Into Second Half of 2027

THOMSON REUTERS
·
Nov 03

Precision BioSciences, Inc. Q3 Income From Operations USD -20.667 Million

THOMSON REUTERS
·
Nov 03

Precision BioSciences Inc Q3 Shr View $-1.34 -- Lseg Ibes Data

THOMSON REUTERS
·
Nov 03

Precision BioSciences Inc expected to post a loss of $1.34 a share - Earnings Preview

Reuters
·
Oct 31

Press Release: Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025

Dow Jones
·
Oct 31